NasdaqCM - Delayed Quote USD

Evaxion Biotech A/S (EVAX)

1.4500
-0.0300
(-2.03%)
At close: May 8 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,344
3,344
73
0
0
Operating Expense
18,076
18,076
22,270
25,264
25,834
Operating Income
-14,732
-14,732
-22,197
-25,264
-25,834
Net Non Operating Interest Income Expense
-708
-708
-743
-785
-159
Other Income Expense
4,085
4,085
25
2,108
1,283
Pretax Income
-11,355
-11,355
-22,915
-23,941
-24,710
Tax Provision
-788
-788
-790
-772
-178
Net Income Common Stockholders
-10,567
-10,567
-22,125
-23,169
-24,532
Diluted NI Available to Com Stockholders
-10,567
-10,567
-22,125
-23,169
-24,532
Basic EPS
-14.00
-10.00
-40.50
-49.00
-63.00
Diluted EPS
-14.00
-10.00
-40.50
-49.00
-63.00
Basic Average Shares
923.9890
1,072.8900
546.7170
472.7740
389.8630
Diluted Average Shares
923.9890
1,072.8900
546.7170
472.7740
389.8630
Total Operating Income as Reported
-14,732
-14,732
-22,197
-25,264
-25,834
Total Expenses
18,076
18,076
22,270
25,264
25,834
Net Income from Continuing & Discontinued Operation
-10,567
-10,567
-22,125
-23,169
-24,532
Normalized Income
-14,368.5143
-14,368.5143
-22,149.1381
-25,192.6800
-25,802.1700
Interest Income
254
254
154
13
0
Interest Expense
962
962
897
798
159
Net Interest Income
-708
-708
-743
-785
-159
EBIT
-10,393
-10,393
-22,018
-23,143
-24,551
EBITDA
-9,786
-9,786
-21,403
-22,572
-24,207
Reconciled Depreciation
607
607
615
571
344
Net Income from Continuing Operation Net Minority Interest
-10,567
-10,567
-22,125
-23,169
-24,532
Total Unusual Items Excluding Goodwill
4,085
4,085
25
2,108
1,283
Total Unusual Items
4,085
4,085
25
2,108
1,283
Normalized EBITDA
-13,871
-13,871
-21,428
-24,680
-25,490
Tax Rate for Calcs
0.0001
0.0001
0
0
0
Tax Effect of Unusual Items
283.4857
283.4857
0.8619
84.3200
12.8300
12/31/2021 - 2/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IOBT IO Biotech, Inc.
0.9900
+0.51%
 
VRAX Virax Biolabs Group Limited
1.0600
+2.91%
 
OSRH OSR Holdings, Inc.
1.2800
+0.79%
 
GUBRA.CO Gubra A/S
394.60
+2.49%
 
MLEC Moolec Science SA
0.8850
-4.53%
 
PYPD PolyPid Ltd.
2.7200
-3.20%
 
PROK ProKidney Corp.
0.7000
+9.32%
 
ACTU Actuate Therapeutics, Inc. Common stock
9.90
+6.45%
 
ABP Abpro Holdings, Inc.
0.1940
-12.22%
 
GRI GRI Bio, Inc.
1.6000
-10.61%